Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aethlon Medical (AEMD) Total Current Liabilities (2016 - 2025)

Aethlon Medical filings provide 15 years of Total Current Liabilities readings, the most recent being $1.9 million for Q1 2025.

  • On a quarterly basis, Total Current Liabilities rose 3.79% to $1.9 million in Q1 2025 year-over-year; TTM through Mar 2025 was $1.9 million, a 3.79% increase, with the full-year FY2025 number at $1.9 million, up 3.79% from a year prior.
  • Total Current Liabilities hit $1.9 million in Q1 2025 for Aethlon Medical, up from $1.8 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $2.4 million in Q4 2022 to a low of $974349.0 in Q3 2021.
  • Median Total Current Liabilities over the past 5 years was $1.8 million (2023), compared with a mean of $1.7 million.
  • Biggest five-year swings in Total Current Liabilities: tumbled 34.6% in 2021 and later skyrocketed 127.73% in 2022.
  • Aethlon Medical's Total Current Liabilities stood at $1.1 million in 2021, then skyrocketed by 127.73% to $2.4 million in 2022, then fell by 13.77% to $2.1 million in 2023, then decreased by 15.56% to $1.8 million in 2024, then rose by 7.08% to $1.9 million in 2025.
  • The last three reported values for Total Current Liabilities were $1.9 million (Q1 2025), $1.8 million (Q4 2024), and $2.3 million (Q3 2024) per Business Quant data.